News — LOS ANGELES (March 13, 2025) -- of Los Angeles and have entered into a strategic collaboration that aims to enhance and transform healthcare development in the United Kingdom and the United States.
The collaboration brings together two of the world’s leading academic medical institutions, combining their expertise in patient care, leading-edge research and medical innovation.
“Our health systems face common challenges and opportunities. We seek to collaborate with the very best in international healthcare for the benefit of our patients,” said Lawrence Tallon, deputy chief executive, Guy's and St Thomas' NHS Foundation Trust. “Whilst we operate in different countries and contexts, we are completely united by our commitment to the highest-quality patient care, enabled by leading-edge research and innovation.”
The collaboration involves three key components:
- Academic Exchange and Research: Develop mutual knowledge exchange through exploring faculty linkages, potential areas of collaborative research and joint educational initiatives to advance medical science and training.
- Innovation and Commercialization: Jointly facilitate commercialization of new medical technologies and support the next generation of healthcare startups poised to foster change and improve the way care is delivered.
- Advancing Specialty Care in the U.K.: Enhance specialty healthcare delivery in the U.K. by harnessing the expertise of two of the most trusted names in medicine. The initiative aims to address the increasing demand for specialized, high-quality care in the U.K. by promoting innovative care models that prioritize accessibility, excellence and patient-focused solutions.
As part of the collaboration, Cedars-Sinai has opened a clinic at 79 Wimpole St. in the Royal Brompton & Harefield Specialist Care building, providing patients expertise and seamless connections to specialists from the U.K. and the U.S. The London-area clinic offers personalized primary care and concierge medicine in a calming environment with premium service.
“We look forward to collaborating with Cedars-Sinai to explore opportunities in research, foster cross-institutional partnerships between research and industry, and drive innovation in healthcare,” said Nadine Hachach-Haram, director of Clinical Innovation and Strategic Industry Partnerships, Guy's and St Thomas' NHS Foundation Trust. “This is an exciting time to leverage our combined expertise to meet the growing demand for specialized, high-quality care for our patients.”
Cedars-Sinai, one of the top academic healthcare organizations in the U.S., has been named to the Honor Roll for the ninth consecutive year in U.S. 麻豆传媒 & World Report’s "Best Hospitals 2024-25" rankings. The medical center also tied for No. 1 in California and Los Angeles in the U.S. News rankings. In addition, seven specialties were ranked among the top 10 in the U.S.: Cardiology, Heart Surgery & Vascular Surgery; Diabetes & Endocrinology; Gastroenterology & GI Surgery; Neurology & Neurosurgery; Obstetrics & Gynecology; Orthopedics; and Pulmonology & Lung Surgery.
Cedars-Sinai also was recently ranked the No. 1 hospital in the U.S. on , reflecting the organization’s commitment to delivering exceptional patient care, advancing medical research and setting the standard for healthcare excellence. The ranking is based on an analysis of more than 1,000 hospitals and 30,000 data points, evaluating critical factors such as clinical outcomes, physician expertise, research contributions and pricing transparency.
Cedars-Sinai leaders said they are looking forward to partnering with Guy’s and St Thomas’ NHS Foundation Trust to foster innovation that benefits patients in the U.K.
“Through this collaboration with Guy's and St Thomas', we are excited to work with an institution that is committed to pushing the boundaries of medical research, diagnostics and innovation, while remaining deeply driven to furthering Cedars-Sinai’s mission of delivering world-class, patient-centered care that sets new healthcare benchmarks in the U.K. and beyond," said , president and CEO of Cedars-Sinai.
Read more on the Cedars-Sinai Blog:
RSS